HAMMERHEAD RIBOZYME TRAGETED TO MURINE LEUKEMIA VIRUS
HAMMERHEAD RIBOZYME TRAGETED TO MURINE LEUKEMIA VIRUS
批准号:
6107784
负责人:
BIJY K PAL
金额:
$17.52万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-01 至 2000-05-31
关键词:
antileukemic agent antisense nucleic acid antiviral agents chemical cleavage drug design /synthesis /production drug screening /evaluation gene targeting gene therapy genetically modified animals laboratory mouse lymphoma molecular cloning murine leukemia virus neoplasm /cancer therapy nucleic acid sequence ribozymes transfection /expression vector ultraviolet spectrometry viral leukemia virus RNA virus infection mechanism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Murine leukemia viruses (MuLV) have been isolated from the wild mice of So.
California. These non-acute leukemia viruses belong to the family of type
C retroviruses. They do not possess any known oncogene and are unable to
transform cells in culture. However, they cause splenic lymphoma in wild,
as well as, susceptible inbred mice. These wild mouse MuLVs have many
similarities with human T-cell leukemia Virus. As a model for human
lymphoma/leukemia, the wild mouse MuLV-induced splenic lymphoma closely
resembles childhood acute lymphoblastic leukemia. The overall objective of
the present investigation is to develop an anti-retroviral approach which
will cause specific cleavage of the viral RNA, inhibiting virus infection
in a cultured cell and virus-induced splenic lymphoma in mice.
The recent discovery of ribozymes has shown that specific RNA molecules can
work as enzymes and degrade target RNA molecules. Of t he various
ribozymes, the hammerhead ribozyme catalytic domain appears to be the
simplest one, and the catalytic center can be easily incorporated into
anti-sense RNA. Specific targeting of a ribozyme against a particular RNA
inside the cell, however, appears to pose a major problem. In the proposed
study, a hammer-head ribozyme will be designed, synthesized, and targeted
against the MuLV RNA by taking advantage of the psi sequence (retroviral
RNA packaging signal) of an MuLV-based retroviral vector. It is expected
that such a sequence will colocalize the ribozyme and the MuLV genomic RNA
in the cytoplasmic micro-environment of the infected cell, aiding trans-
cleavage of the viral RNA. Additionally, such a ribozyme construct will
also be incorporated in the germline of mice. Protection of the transgenic
mice against virus challenge and mild mouse MuLV 10A1-induced
lymphomagenesis would thus provide a rational basis for extending this
strategy for the treatment of retrovirus-associated human cancer such as T-
cell leukemia and retrovirus induced allied diseases like acquired
immunodeficiency syndrome (AIDS)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HAMMERHEAD RIBOZYME TRAGETED TO MURINE LEUKEMIA VIRUS
-
批准号:6611174
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2002
-
负责人:BIJY K PAL
-
依托单位:
HAMMERHEAD RIBOZYME TRAGETED TO MURINE LEUKEMIA VIRUS
-
批准号:6655871
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2002
-
负责人:BIJY K PAL
-
依托单位:
HAMMERHEAD RIBOZYME TRAGETED TO MURINE LEUKEMIA VIRUS
-
批准号:6618921
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2002
-
负责人:BIJY K PAL
-
依托单位:
HAMMERHEAD RIBOZYME TRAGETED TO MURINE LEUKEMIA VIRUS
-
批准号:6496947
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2001
-
负责人:BIJY K PAL
-
依托单位:
HAMMERHEAD RIBOZYME TRAGETED TO MURINE LEUKEMIA VIRUS
-
批准号:6271877
-
项目类别:
-
资助金额:$17.82万
-
财政年份:1998
-
负责人:BIJY K PAL
-
依托单位:
HAMMERHEAD RIBOZYME TRAGETED TO MURINE LEUKEMIA VIRUS
-
批准号:6240654
-
项目类别:
-
资助金额:$14.59万
-
财政年份:1997
-
负责人:BIJY K PAL
-
依托单位:
海外基金